Paul Dabrowski is the founder of Synthego. Synthego has raised $460M in total funding. Latest round: Series E. Based in Redwood City, CA.
Paul Dabrowski is the Co-Founder and CEO of Synthego, a genome engineering company he founded in 2012 with his brother Michael Dabrowski. The company aims to automate and scale CRISPR gene editing technology. Dabrowski leads Synthego's development of full-stack genome engineering tools and cell lines for researchers and therapeutic development.
Full founder directory · Investor directory · Company funding database · Fundraising library